id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-1422-0005,FDA,FDA-2013-N-1422,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approval; Eye Tracking Study of Direct-to-
Consumer Prescription Drug Advertisement Viewing",Notice,General Notice,2014-09-12T04:00:00Z,2014,9,2014-09-12T04:00:00Z,,2014-09-12T14:26:48Z,2014-21728,0,0,090000648186ce62
FDA-2013-N-1422-0004,FDA,FDA-2013-N-1422,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Eye Tracking
Study of Direct-to-Consumer Prescription Drug Advertisement
Viewing",Notice,General Notice,2014-05-28T04:00:00Z,2014,5,2014-05-28T04:00:00Z,2014-06-28T03:59:59Z,2014-05-28T13:46:25Z,2014-12281,0,0,0900006481718c60
FDA-2013-N-1422-0001,FDA,FDA-2013-N-1422,Agency Information Collection Activities; Proposed Collection; Comment Request; Eye Tracking Study of Direct-to-Consumer Prescription Drug Advertisement Viewing,Notice,General Notice,2013-11-29T05:00:00Z,2013,11,2013-11-29T05:00:00Z,2014-01-29T04:59:59Z,2014-09-04T17:41:07Z,2013-28599,0,0,090000648149f075